Angiodynamics (ANGO) Long-Term Deferred Tax (2011 - 2016)

Angiodynamics' Long-Term Deferred Tax history runs 6 years deep, the most recent figure standing at $19.8 million for Q1 2016.

• Quarterly Long-Term Deferred Tax rose 1.42% year-over-year to $19.8 million in Q1 2016, while the trailing twelve-month figure through Feb 2016 was $19.8 million (up 1.42% YoY) and the FY2015 annual result came in at $19.5 million, up 27.87% from the prior year.
• Long-Term Deferred Tax was $19.8 million for Q1 2016 at Angiodynamics, down from $20.0 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $44.3 million in Q2 2012 and bottomed at $5.2 million in Q1 2012.
• A 5-year average of $18.4 million and a median of $18.0 million in 2013 frame the typical range for Long-Term Deferred Tax.
• Annual changes were most pronounced in 2012 — Long-Term Deferred Tax surged 683.5% — and 2013, when it slumped 73.51%.
• Angiodynamics' Long-Term Deferred Tax stood at $38.6 million in 2012, then tumbled by 75.37% to $9.5 million in 2013, then rose by 24.94% to $11.9 million in 2014, then soared by 68.8% to $20.0 million in 2015, then dropped by 1.16% to $19.8 million in 2016.
• Business Quant data shows ANGO's Long-Term Deferred Tax at $19.8 million in Q1 2016, $20.0 million in Q4 2015, and $19.7 million in Q3 2015.